Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Genetic variability in PON1
- PON1 in health and disease
- Goals of presentation
- Origin of paraoxonase name
- Serum PON1 activity
- PON1 polymorphisms
- Additional PON1 SNPs discovered
- Properties of human PON1
- P450-PON pathway for detoxification
- PON1 genetic variability - conseq.
- Determination of PON1 status
- PON1 function in rodent models
- Increased plasma levels of PON1
- High PON1 levels protection
- Low PON1 levels - consequences
- PON1 +/+, +/-, -/- activity levels
- Chlorpyrifos oxon - PON1 +/+, -/-
- Diazoxon - PON1 +/+, +/-, -/-
- Paraoxon - PON1 +/+, +/-, -/-
- In vivo efficacy of PON1 detox.
- Young individuals and OP sensitivity
- Dev. onset of PON1 activity in child.
- Mouse lines carrying human PON1
- hPON1 activity - in Q192/R192 mice
- Sensitivity to CPO toxicity
- Chlorpyrifos oxon exposure
- OP pesticide exposure - conseq.
- Role of PON1192 polymorphism
- Mixed exposures
- Chlorpyrifos oxon/malaoxon expos.
- PON1 mutants - PBPK/PD
- PBPK simulation of AChE activities
- Test of model in PON1 -/- mice
- Genetically variable PON1 status
- PON1 status availability
- Impacts of PON1 genetic variations
- PON1 in health and disease
- Physiological role of PON1
- PON1 activity levels
- PON1 in health and disease
- Important lactone substrates
- Enzymatic activities of hPONs
- Paraoxonases - drug inactiv./activ.
- PON1 in health and disease
- Hydrolysis of 3-O-HSL by PONs
- Avenues of expl. in PON1 KO mice
- OPs detoxication in PON1 KO mice
- The bottom line
- Summary
- PON1 collaborators
- References from the author (1)
- References from the author (2)
- References from the author (3)
Topics Covered
- Paraoxonase (PON1)
- Hydrolytic reactions
- Enzyme properties
- Polymorphisms
- Use of mouse models
- PON1 levels in human populations
- PON1 status as a risk factor in carotid artery disease
- Designing epidemiological studies for examining PON1 genetic variability and risk
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Furlong, C. (2007, October 1). Genetic variability in Paraoxonase 1 (PON1), an HDL associated esterase: impact on risk and pharmacokinetics [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 14, 2024, from https://doi.org/10.69645/BMYL4915.Export Citation (RIS)
Publication History
Financial Disclosures
- Res. Prof. Clement Furlong has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Genetic variability in Paraoxonase 1 (PON1), an HDL associated esterase: impact on risk and pharmacokinetics
A selection of talks on Biochemistry
Hide